Natural Health Products Regulations
Version of section 72 from 2006-03-22 to 2022-06-20:
72 If the authorization to sell or import a natural health product for the purposes of the clinical trial is amended in accordance with subsection 71(5), the sponsor shall
(a) before commencing to sell or import the natural health product in accordance with the amended authorization
(i) cease to sell or import the natural health product in accordance with the existing authorization, and
(ii) maintain records concerning the information referred to in subparagraph 66(c)(ix), if any of that information has changed since it was submitted, and the information referred to in paragraph 66(f); and
(b) conduct the clinical trial in accordance with the amended authorization.
- Date modified: